These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 817665)

  • 1. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.
    Bodey GP; Rodriguez V; Weaver S
    Antimicrob Agents Chemother; 1976 Apr; 9(4):668-74. PubMed ID: 817665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Wald ER; Standiford HC; Tatem BA; Calia FM; Hornick RB
    Antimicrob Agents Chemother; 1975 Mar; 7(3):336-40. PubMed ID: 806263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Aug; 10(2):241-4. PubMed ID: 984764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.
    Lopez CE; Standiford HC; Tatem BA; Calia FM; Schimpff SC; Snyder MJ; Hornick RB
    Antimicrob Agents Chemother; 1977 Mar; 11(3):441-8. PubMed ID: 404963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of piribenicillin, ticarcillin, and carbenicillin against Pseudomonas aeruginosa.
    Murakawa T; Sabath LD
    Antimicrob Agents Chemother; 1977 Jan; 11(1):1-6. PubMed ID: 13704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory studies with a new broad-spectrum penicillin, pirbenicillin.
    Retsema JA; English AR; Lynch JE
    Antimicrob Agents Chemother; 1976 Jun; 9(6):975-82. PubMed ID: 938027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ticarcillin, carbenicillin and ampicillin against some gram-negative bacilli.
    Legakis NJ; Papavassiliou J
    J Antibiot (Tokyo); 1975 Nov; 28(11):912-9. PubMed ID: 811636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies of semisynthetic alpha-(substituted-ureido) penicillins.
    Bodey GP; Stewart D
    Appl Microbiol; 1971 Apr; 21(4):710-7. PubMed ID: 4930281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparity between inhibitory and killing effects of BL-P1654.
    Kurtz S; Holmes K; Turck M
    Antimicrob Agents Chemother; 1975 Feb; 7(2):215-8. PubMed ID: 1137373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azlocillin: in vitro studies of a new semisynthetic penicillin.
    Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
    Monif GR; Clark PR; Shuster JJ; Baer H
    Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin: in vitro evaluation.
    Bodey GP; Le Blanc B
    Antimicrob Agents Chemother; 1978 Jul; 14(1):78-87. PubMed ID: 28694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ; Prior RB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.
    Watanakunakorn C; Bannister T
    Antimicrob Agents Chemother; 1974 Oct; 6(4):471-3. PubMed ID: 4157347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of ticarcillin and carbenicillin against 100 clinical isolates of Pseudomonas aeruginosa.
    Pearman JW; Kosaras FP; Harper WE
    Med J Aust; 1978 Apr; 1(8):452-4. PubMed ID: 96319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new pencillin with anti-klebsiella activity: 3-(5-tetrazolyl) penam.
    Bodey GP; Weaver S; Pan T
    J Antibiot (Tokyo); 1977 Sep; 30(9):724-9. PubMed ID: 924895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative "in vitro" activity of pirbenicillin and carbenicillin against clinical and environmental "Pseudomonas aeruginosa" isolates from hospitals.
    Castellani Pastoris M; Mondello F; Gennaro ML; Greco D
    Ann Sclavo; 1980; 22(6):931-9. PubMed ID: 6794465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.